28 March 2017 - President Donald Trump is planning to take the ax to FDA regulations. 

“[We’re] going to be streamlining the process so that, from your standpoint, when you have a drug, you can actually get it approved instead of waiting for many, many years,” he told a collection of Big Pharma CEOs, including the chief executives of Merck, Novartis and Johnson & Johnson, during a White House meeting earlier this year.

It’s a cause the President has been championing for a while. Trump has promised to roll back 75% to 80% of the agency’s regulations and doubled down on the vow during his February address to a joint session of Congress. “If we slash the restraints, not just at the FDA but across our government, then we will be blessed with far more miracles just like Megan,” he said, referring to a young woman in the audience suffering from a rare disease and whose life was saved thanks to a breakthrough treatment.

Read Fortune Magazine article